Testing version — LOERadar is in active testing. Features and data may change.
INTEGRILIN (EPTIFIBATIDE) | LOERadar
INTEGRILIN
NDA
EPTIFIBATIDE | N020718 | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
INJECTABLE;INJECTION | Approved: May 18, 1998
No patent or exclusivity listings for this strength.
#002 — 75MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**